Brief: Teva And Medincell’S Risperidone Lai Approved In Canada As Longavo®

Medincell SA

23/09/2025 17:02

Sept 23 (Reuters) - Medincell SA MEDCL.PA:

TEVA AND MEDINCELL’S RISPERIDONE LAI APPROVED IN CANADA AS LONGAVO®

Source text: nBw2BQ2G7a

Further company coverage: MEDCL.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))